Although larger cohorts must be analyzed to confirm the biomarker status of MDL1 and MDL1AS, our study identifies this neglected region of the mitochondrial genome as a very informative area for cancer biology that deserves further interest. The gene discussed is CLEC5A; the disease is cancer.